We are live on
!
Find out more
Eli Lilly
1,515 hedge funds and large institutions have $83.2B invested in Eli Lilly in 2019 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 480 increasing their positions, 666 reducing their positions, and 153 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
28% less repeat investments, than reductions
Existing positions increased: 480 | Existing positions reduced: 666
42% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 153
49% less funds holding in top 10
Funds holding in top 10: 49 → 25 (-24)
Holders
1,515
Holding in Top 10
25
Calls
$434M
Puts
$534M
Top Buyers
| 1 | +$851M | |
| 2 | +$457M | |
| 3 | +$187M | |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$184M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$177M |
Top Sellers
| 1 | -$1.64B | |
| 2 | -$685M | |
| 3 | -$574M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$397M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$300M |